Lupus Trials News
June 20, 2019 As reported by the National Institutes of Health (NIH), research published by the NIH Accelerating Medicines Partnership (AMP)...Read More
June 12, 2019 A study presented at EULAR showed that ongoing maintenance therapy with the immunosuppressive drug cyclosporine helped lower...Read More
June 18, 2019 A common type of bacteria living in the gut may spark a common lupus complication called antiphospholipid...Read More
Kezar Life Sciences announced positive results from the MISSION Phase 1 study testing the investigational KZR-616 as a treatment for...Read More
Results of two analyses from a Phase 2 study of Stelara® (ustekinumab) in lupus showed the drug’s effectiveness over one...Read More
June 13, 2019 A study published in Arthritis & Rheumatology found that rituximab was helpful as a maintenance therapy for...Read More
MADRID, Spain. June 13, 2019 – Results of the first clinical trial sponsored by the Lupus Research Alliance and conducted...Read More
June 13, 2019 New results from a clinical study with healthy volunteers found the investigational compound NKTR-358 safe and well-tolerated,...Read More
June 12, 2019 As reported by The Rheumatologist, Dr. Richard Furie provided his perspective on clinical trials in lupus in...
NEW YORK, NY. June 11, 2019. The Lupus Research Alliance is pleased to share positive topline results from a Phase...Read More
May 20, 2019 The LRA applauds Betty Diamond, MD for being named a Distinguished Fellow by the American Association of...Read More
May 20, 2019 It’s Clinical Trials Day when the Lupus Research Alliance recognizes all the people we support who advance...Read More
May 1, 2019 The Lupus Research Alliance is honored to serve the lupus community as the global leader in lupus...Read More
April 29, 2019 Pregnant women with lupus are more likely to suffer complications than those who don’t. Lupus Research Alliance...Read More
April 24, 2019 The pharmaceutical company Exagen, Inc. announced study results showing that a component of their AVISE SLE Monitor...Read More
April 18, 2019 A large international study has probed the causes of lupus-related psychosis—a serious condition marked by delusions and...Read More
April 11, 2019 The Lupus Research Alliance is pleased to share the results from four clinical trials presented at LUPUS...Read More
April 11, 2019 The bacteria that cause urinary tract infections may trigger lupus flares, a former Alzheimer’s disease therapy has...Read More
New results partially funded by the Lupus Research Alliance found that people with systemic lupus erythematosus have almost double the...Read More
March 28, 2019 A new study published this March in Arthritis & Rheumatology found that deaths among patients with end-stage...Read More
March 19, 2019 A new study published in Lupus showed that mycophenolate mofetil (MMF) is comparable in effectiveness to the...Read More
March 1, 2019 Proteins of the immune system, known as type I interferons, are responsible in part for manifestations of...
February 22, 2019 A study published in the peer-reviewed journal Arthritis & Rheumatology found that people with SLE and particularly...
February 22, 2019 Study results published in the peer-reviewed journal PLOS One showed that elements of physical fitness — muscle...
A study just published in Annals of Internal Medicine showed that kidney transplantation reduced deaths due to lupus nephritis— kidney inflammation caused by lupus....
An observational study published in Lupus of people with lupus found that of six factors, stress, depression and pain contributed most to...
A small randomized Phase 1 study published in Arthritis & Rheumatology found that the existing asthma treatment omalizumab (Xolair) may improve lupus...
Source: Idorsia LTD Press Release Idorsia Ltd (SIX: IDIA) announced that the first patient has been enrolled into a multiple-dose study...
A study just published in Clinical and Experimental Rheumatologyfound that exposure to periodontal bacteria on the gums around the teeth can...